Table 2.
Magnitude of UI problem by cancer among those who reported UI1
|
Bladder |
Breast |
Colorectal |
Endo/ Uterine |
Lung |
Prostate |
No cancer |
||
|---|---|---|---|---|---|---|---|---|
|
N (%) |
N (%) |
N (%) |
N (%) |
N (%) |
N (%) |
N (%) |
||
| N=280 | N=1,296 | N=635 | N=299 | N=241 | N=1,416 | N=113,995 | ||
| Magnitude of UI problem |
Big |
50 (13.3) |
240 (14.9) |
120 (13.9) |
60 (20.1) |
47 (14.2) |
266 (14.5) |
20,675 (13.1) |
| Small |
174 (46.3) |
769 (47.9) |
380 (44.0) |
169 (56.4) |
150 (45.3) |
839 (45.7) |
69,052 (43.9) |
|
| Not a problem |
152 (40.4) |
597 (37.2)** |
364 (42.1) |
70 (23.5) |
134 (40.5) |
731 (39.8)* |
67,607 (43.0) |
|
| Talked to physician about UI |
Yes |
175 (54.3)** |
514 (36.9) |
257 (34.0) |
112 (44.4) |
110 (37.7) |
878 (56.5)** |
47,655 (35.4) |
| Received treatment for UI | Yes | 107 (37.4)** | 291 (24.9) | 135 (21.4) | 74 (37.0) | 50 (19.2) | 477 (34.0)** | 27,238 (24.1) |
1Two-tailed p-value for chi-squared test, comparing distribution of covariate of cancer group to no cancer group.
* p <0.05.
**p<0.01.